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Background
Infectious diseases (ID) are the second cause of death
after cardiovascular diseases worldwide; severe sepsis
and septic shock, syndromes induced by infection have
an increasing incidence and high mortality requiring
diagnosis and intensive therapy and appropriate attitude.
Objectives: to establish the clinical, evolutive and etiolo-
gical aspects of ID evolving critically ill patients with ID.
Methods
Retrospective study (January 2013-March 2013) on 96
critically ill patients with ID hospitalized in the Intensive
Care Unit of the “Victor Babeş” Hospital Craiova.
Results
General data of the study lot: gender distribution was
balanced (M:F = 1:1), 75% of patients were from urban
areas and the median age was 60 (IQR: 1-95) years. ID
were: respiratory infection (67.71%), gastrointestinal
(12.50%), urinary (9.37%), neurological (9.37%) and car-
diovascular (1.05%). Failure or organ dysfunction (one
or combination) in the study group: respiratory
(69.79%), neurological (9.37%), renal (5.21%), liver
(1.04%), hematologic (1.04%) and heart (1.04%). Sepsis
was diagnosed in 35.42% of patients, severe sepsis in
22.92% and 5.21% developed septic shock.
Comorbidities were identified in 88.54% of patients
(one or combination) as follows: chronic cardiovascular
diseases – 39.58% of patients, neuropsychiatric – 16.67%,
pulmonary – 12.5%, obesity – 10.42%, HIV – 9.37%, uro-
genital – 8.33%, diabetes and cancer – 7.29% each, other
– 11.46%. Favorable outcome was recorded in 88.54% of
cases, death was recorded in 11.46% of cases. The etiol-
ogy had been identified in 32.29% of the cases, as follows:
bacterial etiology – 74.20% of the cases, viral and parasi-
tic each in 12.90%. The etiology of ID was represented
by: Gram-negative bacteria (38.71%), Gram-positive bac-
teria (22.58%), Mycobacterium tuberculosis and Toxo-
plasma gondii (12.90% in each case), measles virus
(9.68%) and pdm2009 influenza virus (3.23%).
Conclusion
Critically ill patients with ID presented most commonly
respiratory or gastrointestinal infection and most fre-
quently developed respiratory or neurological failure or
dysfunction. Most critically ill patients with ID asso-
ciated comorbidities, most commonly chronic cardiovas-
cular diseases. Evolving critically ill patients with ID had
significantly increased risk of death. Gram-negative bac-
teria dominated the etiology of ID in critically ill
patients, followed by Gram-positive bacteria.
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